Rastetter William H is a director of Neurocrine Biosciences, Inc.
Person profile
Roles
Neurocrine Biosciences
Director
Regulus Therapeutics
Director
Dare Bioscience
Director
Fate Therapeutics
Director
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NEUROCRINE BIOSCIENCES INC
4 Jan 24
144
NEUROCRINE BIOSCIENCES INC
2 Jan 24
4
Regulus Therapeutics Inc.
14 Aug 23
4
Dare Bioscience, Inc.
21 Jun 23
4
Regulus Therapeutics Inc.
13 Jun 23
4
FATE THERAPEUTICS INC
7 Jun 23
4
NEUROCRINE BIOSCIENCES INC
19 May 23
4
NEUROCRINE BIOSCIENCES INC
3 May 23
144
NEUROCRINE BIOSCIENCES INC
1 May 23
4
NEUROCRINE BIOSCIENCES INC
21 Apr 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 131.4675 | 11,044 | 1.45 mm | 51,741 |
2 Jan 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 12.98 | 20,000 | 259.60 k | 62,785 |
2 Jan 24 | NBIX Neurocrine Biosciences | NQSO Common Stock | Option exercise | Dispose M | No | No | 12.98 | 20,000 | 259.60 k | 0 |
10 Aug 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.36 | 15,000 | 20.40 k | 15,000 |
21 Jun 23 | DARE Dare Bioscience | Stock Option Common stock | Grant | Acquire A | No | No | 0.96 | 40,000 | 38.40 k | 40,000 |
13 Jun 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.45 | 30,000 | 43.50 k | 30,000 |
6 Jun 23 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.52 | 40,000 | 220.80 k | 40,000 |